Extracellular matrix alterations in low‐grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry
- 21 February 2020
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 55 (4) , e4450
Abstract
Lung adenocarcinoma (LUAD) is the second most common cancer, affecting both men and women. Fibrosis is a hallmark of LUAD occurring throughout progression with excess production of extracellular matrix (ECM) components that lead to metastatic cell processes. Understanding the ECM cues that drive LUAD progression has been limited due to a lack of tools that can access and report on ECM components within the complex tumor microenvironment. Here, we test whether low‐grade LUAD can be distinguished from normal lung tissue using a novel ECM imaging mass spectrometry (ECM IMS) approach. ECM IMS analysis of a tissue microarray with 20 low‐grade LUAD tissues and 20 normal lung samples from 10 patients revealed 25 peptides that could discriminate between normal and low‐grade LUAD using area under the receiver‐operating curve (AUC) ≥0.7, P value ≤.001. Principal component analysis demonstrated that 62.4% of the variance could be explained by sample origin from normal or low‐grade tumor tissue. Additional work performed on a wedge resection with moderately differentiated LUAD demonstrated that the ECM IMS analytical approach could distinguish LUAD spectral features from spectral features of normal adjacent lung tissue. Conventional liquid chromatography with tandem mass spectrometry (LC‐MS/MS) proteomics demonstrated that specific sites of hydroxylation of proline (HYP) were a main collagen post translational modification that was readily detected in LUAD. A distinct peptide from collagen 3A1 modified by HYP was increased 3.5 fold in low‐grade LUAD compared with normal lung tissue (AUC 0.914, P value <.001). This suggests that regulation of collagen proline hydroxylation could be an important process during early LUAD fibrotic deposition. ECM IMS is a useful tool that may be used to define fibrotic deposition in low‐grade LUAD.Keywords
Funding Information
- National Cancer Institute (P30 CA138313)
- National Institute of General Medical Sciences (P20GM103542)
- Office of Disease Prevention (S10 OD010731, S10 OD025126)
- Medical University of South Carolina (P30 CA138313)
- National Heart, Lung, and Blood Institute (HL007260)
This publication has 36 references indexed in Scilit:
- Byonic: Advanced Peptide and Protein Identification SoftwareCurrent Protocols in Bioinformatics, 2012
- Structure of collagenase G reveals a chew-and-digest mechanism of bacterial collagenolysisNature Structural & Molecular Biology, 2011
- Extracellular Matrix Degradation and Remodeling in Development and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Collagen Structure and StabilityAnnual Review of Biochemistry, 2009
- Collagen‐Targeted MRI Contrast Agent for Molecular Imaging of FibrosisAngewandte Chemie International Edition, 2007
- Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to AdultCirculation, 2006
- Tensional homeostasis and the malignant phenotypeCancer Cell, 2005
- Collagens—structure, function, and biosynthesisAdvanced Drug Delivery Reviews, 2003
- How does the extracellular matrix direct gene expression?Journal of Theoretical Biology, 1982